US 11572372
Anti-HBVtetrahydroisoxazolo[4,3-c]pyridine compounds
granted A61KA61K31/424A61K31/4355
Quick answer
US patent 11572372 (Anti-HBVtetrahydroisoxazolo[4,3-c]pyridine compounds) held by Medshine Discovery Inc. expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Feb 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/424, A61K31/4355, A61K31/437, A61P